Publication: Antiproliferative and apoptosis induction of α-mangostin in T47D breast cancer cells
| dc.contributor.author | Kritsanawong S. | |
| dc.contributor.author | Innajak S. | |
| dc.contributor.author | Imoto M. | |
| dc.contributor.author | Watanapokasin R. | |
| dc.date.accessioned | 2021-04-05T03:23:54Z | |
| dc.date.available | 2021-04-05T03:23:54Z | |
| dc.date.issued | 2016 | |
| dc.date.issuedBE | 2559 | |
| dc.description.abstract | α-Mangostin extracted from mangosteen, Garcinia mangostana Linn. is known as 'queen of fruits'. The anticancer activity of α-mangostin through apoptosis induction and related signaling pathways in human breast cancer T47D cells was investigated. Human epidermal growth factor receptor 2 (HER2) and mitogen-activated protein kinase (MAPK) signaling have been shown to play important roles in apoptosis. The results showed that α-mangostin induced cell proliferation inhibition, DNA fragmentation, nuclear condensation, increased cleaved caspase-3 and cleaved caspase-9, but decreased Bcl-2 and Mcl-1 expression. Mitochondrial dysfunction and cytochrome c release were also detected. In addition, phosphorylation of ERα, HER2, PI3K, Akt and ERK1/2 were downregulated whereas p-JNK1/2 and p-p38 were upregulated. These results indicated that α-mangostin induced apoptosis associated with HER2/PI3K/Akt and MAPK signaling pathways suggesting that α-mangostin may be used as food supplement or a potential therapeutic compound for breast cancer. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | International Journal of Oncology. Vol 48, No.5 (2016), p.2155-2165 | |
| dc.identifier.doi | 10.3892/ijo.2016.3399 | |
| dc.identifier.issn | 10196439 | |
| dc.identifier.other | 2-s2.0-84962623421 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/5440 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | Alpha mangostin | |
| dc.subject.other | Antineoplastic agent | |
| dc.subject.other | Caspase 3 | |
| dc.subject.other | Caspase 9 | |
| dc.subject.other | Cytochrome c | |
| dc.subject.other | DNA | |
| dc.subject.other | Epidermal growth factor receptor 2 | |
| dc.subject.other | Estrogen receptor alpha | |
| dc.subject.other | Mitogen activated protein kinase 1 | |
| dc.subject.other | Mitogen activated protein kinase 3 | |
| dc.subject.other | Mitogen activated protein kinase p38 | |
| dc.subject.other | Phosphatidylinositol 3 kinase | |
| dc.subject.other | Plant extract | |
| dc.subject.other | Protein bcl 2 | |
| dc.subject.other | Protein kinase B | |
| dc.subject.other | Protein mcl 1 | |
| dc.subject.other | Raf protein | |
| dc.subject.other | Stress activated protein kinase 1 | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Antineoplastic agent | |
| dc.subject.other | Epidermal growth factor receptor 2 | |
| dc.subject.other | ERBB2 protein, human | |
| dc.subject.other | Mangostin | |
| dc.subject.other | Xanthone derivative | |
| dc.subject.other | Antiproliferative activity | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Article | |
| dc.subject.other | Breast cancer cell line | |
| dc.subject.other | Cell cycle | |
| dc.subject.other | Cell nucleus | |
| dc.subject.other | Cell proliferation | |
| dc.subject.other | Cell viability | |
| dc.subject.other | Colony formation | |
| dc.subject.other | Controlled study | |
| dc.subject.other | DNA fragmentation | |
| dc.subject.other | Down regulation | |
| dc.subject.other | Drug isolation | |
| dc.subject.other | Drug mechanism | |
| dc.subject.other | Drug structure | |
| dc.subject.other | Enzyme release | |
| dc.subject.other | Fruit | |
| dc.subject.other | Garcinia mangostana | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | IC50 | |
| dc.subject.other | Mitochondrial membrane potential | |
| dc.subject.other | Priority journal | |
| dc.subject.other | Protein cleavage | |
| dc.subject.other | Protein expression | |
| dc.subject.other | Protein phosphorylation | |
| dc.subject.other | Signal transduction | |
| dc.subject.other | T47D cell line | |
| dc.subject.other | Western blotting | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Breast Neoplasms | |
| dc.subject.other | Cell survival | |
| dc.subject.other | Drug effects | |
| dc.subject.other | Female | |
| dc.subject.other | Gene expression regulation | |
| dc.subject.other | Metabolism | |
| dc.subject.other | Phosphorylation | |
| dc.subject.other | Tumor cell line | |
| dc.subject.other | Antineoplastic Agents | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Breast Neoplasms | |
| dc.subject.other | Cell Line, Tumor | |
| dc.subject.other | Cell Proliferation | |
| dc.subject.other | Cell Survival | |
| dc.subject.other | DNA Fragmentation | |
| dc.subject.other | Female | |
| dc.subject.other | Gene Expression Regulation, Neoplastic | |
| dc.subject.other | Humans | |
| dc.subject.other | MAP Kinase Signaling System | |
| dc.subject.other | Membrane Potential, Mitochondrial | |
| dc.subject.other | Phosphorylation | |
| dc.subject.other | Receptor, ErbB-2 | |
| dc.subject.other | Xanthones | |
| dc.title | Antiproliferative and apoptosis induction of α-mangostin in T47D breast cancer cells | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962623421&doi=10.3892%2fijo.2016.3399&partnerID=40&md5=078d7c13cd4eba425924c821b30a40e7 |
